Table: SymBio Pharmaceuticals - 6-MTH group results
Aug 4 (Reuters)-
SymBio Pharmaceuticals Limited
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
6 months ended 6 months ended Year to
Jun 30, 2022 Jun 30, 2021 Dec 31, 2022
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 4.87 10.00
Operating 1.37 1.77
Recurring 1.45 1.75
Net 1.11 1.48
EPS 28.71 yen 38.35 yen
EPS Diluted 28.32 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - SymBio Pharmaceuticals Limited.
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T